By enhancing ALDH2 expression specifically in CVECs, we facilitate clearance of these toxic aldehydes, thus mitigating the cascade of oxidative injury that contributes to endothelial dysfunction and loss. This evidence concerns the gene ALDH2 and endothelial dysfunction.